A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion
Mustafa Khasraw, Kelly Hotchkiss, Kenan Zhang, Anna Corcoran, Elizabeth Owens, Pamela Noldner, Chelsea Railton, Kyra Van Batavia, Ying Zhou, Jodie Jepson, Kirit Singh, Roger McLendon, Kristen Batich, Anoop Patel, Katayoun Ayasoufi, Michael Brown, Evan Calabrese, Jichun Xie

TL;DR
This study identifies factors in gliomas that allow T cells to expand, which could improve immunotherapy for brain cancer.
Contribution
The paper introduces a spatial multi-omic framework to identify gliomas suitable for TIL expansion.
Findings
IL7R expression and perivascular immune clustering correlate with successful TIL expansion.
TIL− tumors show neuronal lineage signatures and immunosuppressive markers like TOX and FERMT1.
The profiling method is being used in the GIANT clinical trial for glioblastoma and immune-excluded cancers.
Abstract
Tumor-infiltrating lymphocyte (TIL) therapy, recently approved by the FDA for melanoma, is an emerging modality for cell-based immunotherapy. However, its application in immunologically “cold” tumors such as glioblastoma remains limited due to sparse T cell infiltration, antigenic heterogeneity, and a suppressive tumor microenvironment. To identify genomic and spatial determinants of TIL expandability, we performed integrated, multimodal profiling of high-grade gliomas using spectral flow cytometry, TCR sequencing, single-cell RNA-seq, Xenium in situ transcriptomics, and CODEX spatial proteomics. Comparative analysis of TIL-generating (TIL+) versus non-generating (TIL−) tumors revealed that IL7Rexpression, structured perivascular immune clustering, and tumor-intrinsic metabolic programs such as ACSS3 were associated with successful TIL expansion. In contrast, TIL−tumors were enriched…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGlioma Diagnosis and Treatment · Ferroptosis and cancer prognosis · Single-cell and spatial transcriptomics
